Zepbound Bests Wegovy for Weight Loss in New Trial

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly.

"Given the increased interest around obesity medications, we conducted this study to help health care providers and patients make informed decisions about treatment choice," Dr. Leonard Glass...

E. Coli Outbreak Linked to McDonald's Quarter Pounders Declared Over

WEDNESDAY, Dec. 4, 2024 (Healtday News) -- An investigation into an E. coli outbreak linked to McDonald's Quarter Pounders has officially been closed, the U.S. Food and Drug Administration announced Tuesday.

In total, 104 people from 14 states were sickened and 34 were hospitalized during the outbreak, while one older person in Colorado di...

Almost a Third of U.S. Retail Pharmacies Have Closed Since 2010

About a third of America’s pharmacies have closed since 2010, amounting to an “unprecedented decline” in neighborhood drug stores, a new study finds.

The drop began in 2018, primarily driven by store closures among chain pharmacies during a period of consolidation in the industry, researchers found.

This has made it...

20th Century Lead Exposures Took Grim Toll on Americans' Health

Decades of lead exposure from car exhaust altered the mental health of millions of Americans, making them more prone to depression, anxiety and ADHD, a new study claims.

Lead was first added to gasoline in 1923 to help keep car engines healthy, researchers said.

But lead is toxic to brain cells, and there’s no safe level of exp...

American Seniors Struggle to Pay Medical Bills More Than Peers in Other Wealthy Countries

American seniors still pay more for health care than their counterparts in most other wealthy countries do, despite coverage by Medicare, a new study finds.

They are also more likely to postpone or skip needed care because of cost concerns.

“In the U.S., nearly all older adults are covered by Medicare and can access, at minimum...

New Weight-Loss Advance: A Gastric Balloon You Control to Feel Full or Not

GLP-1 meds are all the rage for weight loss nowadays, but not everyone can safely take the drugs to shed pounds. Invasive weight-loss surgeries can often be a tough sell, too.

Now, researchers at the Massachusetts Institute of Technology (MIT) say they've developed an alternative: A small, implanted gastric balloon that people can inflate...